• 3-Deazaneplanocin (DZNep): Reliable Epigenetic Modulator for

  2026-08-03

  This article offers scenario-driven, evidence-based guidance for using 3-Deazaneplanocin (DZNep, SKU A1905) in cell-based assays targeting oncology and metabolic disease models. With a focus on protocol optimization, reproducibility, and vendor reliability, it empowers researchers to maximize data quality and workflow efficiency.

• Silybin A in Silymarin: Translational Leverage for Liver Dis

  2026-08-03

  This thought-leadership article explores the mechanistic and strategic landscape of Silybin A—a principal flavonolignan in Silymarin—focusing on its antioxidant, anti-inflammatory, and hepatoprotective mechanisms relevant to advanced liver disease and metabolic research. It synthesizes biochemical insight, protocol guidance, and translational strategy, offering a roadmap for researchers seeking rigor and impact in hepatoprotection and metabolic modulation studies.

• M344 Histone Deacetylase Inhibitor: Protocols and Innovation

  2026-08-02

  M344 stands out as a potent, cell-permeable histone deacetylase inhibitor, enabling advanced cancer and HIV latency research with unmatched precision. This article delivers actionable protocols, experimental insights, and troubleshooting strategies that maximize the value of M344 in epigenetic and oncology workflows.

• EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1

  2026-08-01

  EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent optimized for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide coupling workflows. It is strictly intended for in vitro laboratory use and is not recommended for in vivo or clinical research due to the absence of supporting data.

• CKI 7 dihydrochloride: Advanced Insights for CK1 Pathway Res

  2026-07-31

  Explore how CKI 7 dihydrochloride, a selective Casein kinase 1 inhibitor, enables deeper mechanistic studies in Wnt signaling, circadian rhythm regulation, and cancer biology. This article delivers unique assay design guidance and translational insight not found in existing resources.

• ATG4B Nuclear Translocation Links Energy Deficiency to AML P

  2026-07-31

  This study uncovers a direct molecular mechanism by which cellular energy deficiency impairs DNA repair in acute myeloid leukemia (AML) via ATG4B nuclear translocation and inhibition of PRMT1-mediated MRE11 methylation. The findings highlight a new therapeutic target for mitigating genomic instability and leukemic progression, with implications for metabolic-genomic crosstalk in cancer.

• 5X Protein Loading Buffer (Reducing): SDS-PAGE Protocol Guid

  2026-07-30

  5X Protein Loading Buffer (Reducing) simplifies protein sample preparation for SDS-PAGE by ensuring complete denaturation and reduction of disulfide bonds. It is essential for workflows requiring molecular weight-based protein separation under reducing conditions and should not be used for native or non-reducing analyses.

• Z-LEHD-FMK: Irreversible Caspase-9 Inhibitor in Apoptosis As

  2026-07-30

  Z-LEHD-FMK empowers researchers to dissect mitochondria-mediated apoptosis with exceptional specificity and workflow reliability. Its proven use in cancer, neuroprotection, and advanced apoptosis assays unlocks both mechanistic insight and robust, reproducible results.

• Structural Insights into ω-Agatoxin IVA Sensitivity in Cav2.

  2026-07-29

  This study reveals the molecular determinants underlying the variable sensitivity of P- and Q-type Cav2.1 channels to ω-agatoxin IVA. High-resolution cryo-EM structures clarify how specific extracellular loop configurations and alternative splicing define toxin binding, providing a blueprint for targeted modulation of synaptic transmission and neuroprotection strategies.

• Amiloride (MK-870): Optimizing Sodium Channel Research Workf

  2026-07-29

  Amiloride (MK-870) stands out as a dual-action epithelial sodium channel and uPAR inhibitor, empowering researchers to dissect ion transport and endocytosis pathways. This guide translates recent mechanistic insights into actionable, workflow-driven strategies for advanced sodium channel research and cellular endocytosis modulation.

• Syringin Enhances Sunitinib Efficacy in RCC via EGFR/PI3K/Ak

  2026-07-28

  This study presents Syringin, a natural compound, as a novel adjunct in renal cell carcinoma (RCC) therapy by promoting apoptosis and overcoming resistance to Sunitinib. Through targeting the EGFR/PI3K/Akt pathway, Syringin enhances Sunitinib sensitivity and efficacy in RCC models, offering a new avenue for combination strategies against treatment-resistant tumors.

• Glioma Organoids with Native Microenvironment Enable Persona

  2026-07-28

  This study presents a novel methodology for generating glioma organoids that retain the complex microenvironment and cellular interactions of the original tumor. By preserving both genetic/epigenetic fidelity and immune cell composition, the model improves the accuracy of drug screening and therapeutic evaluations in glioma research.

• Diminazene Aceturate in Advanced Mitochondrial and Parasitic

  2026-07-27

  This article provides scenario-driven insights into the application of Diminazene Aceturate (SKU B1729) for cell viability, mitochondrial biogenesis, and trypanosome parasite assays. Addressing real-world laboratory challenges, we discuss protocol optimization, data interpretation, and product reliability, with actionable guidance for biomedical researchers seeking reproducible results using Diminazene Aceturate.

• 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture:

  2026-07-27

  This scenario-driven guide explores how the 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture (SKU K1041) addresses persistent challenges in molecular biology assays—offering researchers reproducible outcomes and workflow efficiency. Drawing on published literature and real-world use cases, we examine optimized protocols, troubleshooting strategies, and the practical value of this DNA synthesis reagent for cell viability, proliferation, and nucleic acid delivery studies.

• Caspase-3 Colorimetric Assay Kit: Practical Use and Protocol

  2026-07-26

  The Caspase-3 Colorimetric Assay Kit enables sensitive measurement of DEVD-dependent caspase-3 activity in biological samples, supporting research in apoptosis and neurodegenerative diseases. It is best suited for labs seeking robust, quantitative apoptosis assays, but is not intended for mechanistic studies beyond caspase-3 or for unsupported sample types.

16821 records 1/1122 page Next 12345 下5页 Last page